CrossrefInfokarte
Gatekeeper V561M mutations as a mechanism of resistance to relapsed/refractory hematologic malignancies treated with Pemigatinib
International Journal of Cancer Care and Delivery · 2025
DOI: 10.53876/001a.129570 ↗Abstract
Kein Abstract verfügbar.
EUVIMED